Datasets of a novel bivalent single chain antibody constructed by overlapping oligonucleotide annealing method targeting human CD123

Current therapies for acute myeloid leukemia (AML), are associated with high relapse rates. Hence, development of new therapeutic strategies is crucial to circumvent this problem. Bivalent antibody technology has been used to engineer novel antibody fragments with increased avidity, by assembling tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Moradi-Kalbolandi, Shima, Habibi-Anbouhi, Mahdi, Golkar, Majid, Behdani, Mahdi, Rezaei, Gashin, Ghazizadeh, Leila, Abolhassani, Mohsen, Shokrgozar, Mohammad Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Data Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976644/
https://www.ncbi.nlm.nih.gov/pubmed/27536714
http://dx.doi.org/10.1016/j.dib.2016.07.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976644/
https://www.ncbi.nlm.nih.gov/pubmed/27536714
http://dx.doi.org/10.1016/j.dib.2016.07.014

Ejemplares similares